No Prescription |
 |
 | ||
|
Acnecinamide Gel Cream Generic NIACINAMIDE |
|
| ||
No Prescription » Prescription Drugs 1 » Acnecinamide Gel Cream Generic NIACINAMIDE Acnecinamide Gel Cream is a special combination of Niacinamide 4 % (vitamin B3) Evening primrose oil (as linoleic acid source) and Soya genistein (modifies androgen conversion) that helps control of the excessive production of sebum and the prevention of inflammation. Acnecinamide gel cream helps the treatment of all types of acne with mild to moderate lesions and also soothes acne prone skin. Of its special formula not only treats acne lesions but also gives dermal care. The non-oily moisturizing effect of the gel cream makes it ideal for more sensitive skin. Acnecinamide Gel Cream Acnecinamide Gel Cream is 97 % effective in the treatment of acne lesions. Acnecinamide Gel Cream; Controls excessive oil and sebum production Reduces the blackheads and whiteheads on acne or acne prone skin Reduces inflammation red spots and scars Fights against the hormonal effects which lead to pimples Cares for the moisture balance of the skin Soothes blemishes Reduces the acne spots Can be applied on mixed skin type Renews and regenerates the skin. Direction: After cleaning the skin Acnecinamide Gel Cream is applied 2 or 3 times in a day on oily skin areas with acne blemishes pimples and blackheads. Buy Acnecinamide Gel Cream Generic NIACINAMIDE and other Prescription Drugs 1 products online at Medstore. 5793
About Acnecinamide Gel Cream Generic NIACINAMIDE: Product Type: Prescription Drugs 1 Acnecinamide Gel Cream (Generic NIACINAMIDE (VITAMIN B3)) Acnecinamide Gel Cream (Generic NIACINAMIDE) Generic NIACINAMIDE 4% 30oz Generic NIACINAMIDE Acnecinamide Gel Cream
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
